Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor

Mayo Clinic Proceedings

Volumn 77, Issue 7, 2002, Pages 722-728

  Sewani, Hassanali H ^a   Rabatin, Jeffrey T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ELECTROLYTE; HYPERTENSIVE AGENT;

ADULT; ALKALINIZATION; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CRITICAL ILLNESS; FATALITY; FLUID THERAPY; HUMAN; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; LISTERIA; LISTERIOSIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 0036300735     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.7.722     Document Type: Article

References (79)

1. Akuter Harnleiterverschluss nach Bestrahlung chronischer Leukämien mit Röntgenstrahlen
2. Hyperuricemic acute renal failure in disseminated carcinoma
3. Tumor lysis syndrome in nonhematopoietic neoplasms
4. Tumor lysis syndrome in nonhematologic malignancies: Report of a case and review of the literature
5. Spontaneous recurrent tumor lysis syndrome in breast cancer
6. Fatal acute tumor lysis syndrome with metastatic breast carcinoma
7. Tumor lysis syndrome after tamoxifen flare
8. Tumor lysis syndrome in small cell carcinoma and other solid tumors
9. Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma
10. Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma
11. Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin
12. Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung: A case report
13. Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis
14. Acute tumor lysis syndrome with metastatic medulloblastoma: A case report
15. Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma
16. Tumor lysis syndrome after combination chemotherapy for ovarian cancer
17. Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma
18. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: A case report and review of the literature
19. Fatal acute tumor lysis syndrome following treatment of vulvar carcinoma: Case report
20. Acute tumor lysis syndrome associated with paclitaxel
21. Histopathologic classification of small cell lung cancer: Changing concepts and terminology
22. Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma
23. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma
24. Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas
25. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine
26. Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine
27. Brief report: Tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia
28. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia
29. Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hodgkin's lymphoma
30. Acute tumor lysis syndrome following intrathecal methotrexate
31. Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids
32. Dexamethasone-induced tumor lysis syndrome in high-grade non-Hodgkin's lymphoma
33. Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma
34. Acute tumour lysis syndrome in a patient with acute lymphoblastic leukaemia after a single dose of prednisone
35. Acute tumor lysis syndrome in non-Hodgkin lymphoma induced by dexamethasone
36. Corticosteroid induced tumor lysis syndrome in acute lymphoblastic leukemia
37. Radiation induced acute tumor lysis syndrome in the bone marrow transplant setting
38. Spontaneous acute tumor lysis syndrome in acute myeloid leukemia? a single case report with discussion of the literature
39. Acute spontaneous tumor lysis syndrome
40. Oncologic emergencies
41. Tumor lysis syndrome
42. Acute tumour lysis syndrome
43. Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia
44. Hyperkalaemia, a sequel to chemotherapy of Burkitt's lymphoma
45. Extreme hyperkalaemia due to rapid lysis of leukaemic cells
46. Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma
47. Solubility of uric acid and monosodium urate
48. The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout
49. Hyperuricemic nephropathy: Pathologic features and factors influencing urate deposition
50. A micropuncture study of the early phase of acute urate nephropathy
51. Uric acid excretion and renal function in the acute hyperuricemia of leukemia: Pathogenesis and therapy of uric acid nephropathy
52. Hyperuricemic acute renal failure
53. Excretion of phosphate and calcium: Physiology of their renal handling and relation to clinical medicine
54. Studies of the mechanism by which phosphate infusion lowers serum calcium concentration
55. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol
56. A rapid method for the diagnosis of acute uric acid nephropathy
57. Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia
58. Transient acute renal failure due to tumor-lysis-induced severe phosphate load in a patient with Burkitt's lymphoma
59. Adenosine alters glomerular filtration control by angiotensin H
60. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia
61. Tumor lysis syndrome: Pathogenesis and management
62. Postchemotherapy purine excretion in lymphoma patients receiving allopurinol
63. Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failure
64. Allopurinol: Intravenous use for prevention and treatment of hyperuricemia
65. Advances in the management of malignancy-associated hyperuricaemia
66. Urate oxidase in the prophylaxis and treatment of hyperuricemia: The United States experience
67. Physicochemical basis for formation of renal stones of calcium phosphate origin: Calculation of the degree of saturation of urine with respect to brushite
68. Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma
69. Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy
70. Determination of ionized calcium in serum by use of an ion-selective electrode, I: Determination of normal values under physiologic conditions, with comments on the effects of food ingestion and hyperventilation
71. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: Clinical and experimental support for the hypothesis
72. Colonic necrosis with Kayexalate-sorbitol enemas after renal transplantation
73. Bone and soft tissue changes with oral phosphate supplements
74. Inorganic phosphate treatment of hypercalcemia of diverse etiologies
75. High dialysate flow rate continuous arteriovenous hemodialysis: A new approach for the treatment of acute renal failure and tumor lysis syndrome
76. Hyperphosphatemia in tumor lysis syndrome: The role of hemodialysis and continuous veno-venous hemofiltration
77. Continuous hemodiafiltration in children
78. Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: Case report and a review of the literature